Replies to post #13247 on ANI Pharmaceuticals (ANIP)

[SriMaharaj]

Another coverage.

Raymond James analyst Elliot Wilbur maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Outperform and raises the price target from $60 to $65.

[catty]

SriMaharaj: We also need media coverage- ie: Fox Business, CNBC - Barrons, Investors Daily, etc.